First Time Loading...

Yixintang Pharmaceutical Group Co Ltd
SZSE:002727

Watchlist Manager
Yixintang Pharmaceutical Group Co Ltd Logo
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Watchlist
Price: 21.55 CNY -1.33% Market Closed
Updated: May 7, 2024
Section:
 

Relative Value

The Relative Value of one Yixintang Pharmaceutical Group Co Ltd stock under the Base Case scenario is 38.96 CNY. Compared to the current market price of 21.55 CNY, Yixintang Pharmaceutical Group Co Ltd is Undervalued by 45%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
38.96 CNY
Undervaluation 45%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
92
vs Industry
37
Median 3Y
1
Median 5Y
1.2
Industry
0.6
Forward
0.7
More Details
12.5
P/E
P/E
Price to Earnings
12.5
vs History
90
vs Industry
41
Median 3Y
17.4
Median 5Y
20.1
Industry
16.4
Forward
12.4
More Details
5.4
P/OCF
P/OCF
Price to OCF
5.4
vs History
90
vs Industry
46
Median 3Y
7.4
Median 5Y
11.8
Industry
8
More Details
6
P/FCFE
P/FCFE
Price to FCFE
6
vs History
85
vs Industry
45
Median 3Y
7.1
Median 5Y
11.9
Industry
15.7
More Details
1.6
P/B
P/B
Price to Book Value
1.6
vs History
92
vs Industry
40
Median 3Y
2.2
Median 5Y
2.7
Industry
1.6
More Details
0.7
EV/S
EV/S
Enterprise Value to Sales
0.7
vs History
92
vs Industry
39
Median 3Y
1.1
Median 5Y
1.2
Industry
0.7
Forward
0.7
More Details
2.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.2
vs History
92
vs Industry
43
Median 3Y
3
Median 5Y
3.3
Industry
2.2
More Details
9.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.5
vs History
92
vs Industry
29
Median 3Y
14.2
Median 5Y
16
Industry
8.4
Forward
8
More Details
9.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
9.5
vs History
92
vs Industry
43
Median 3Y
14.2
Median 5Y
16
Industry
12.7
Forward
9.7
More Details
5.6
EV/OCF
EV/OCF
Enterprise Value to OCF
5.6
vs History
92
vs Industry
51
Median 3Y
7.8
Median 5Y
11.8
Industry
9.1
More Details
6.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
6.7
vs History
90
vs Industry
47
Median 3Y
9.5
Median 5Y
14.2
Industry
12.6
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
92
vs Industry
34
Median 3Y
1.7
Median 5Y
2.3
Industry
1.1
More Details

Multiples Across Competitors

Competitors Multiples
Yixintang Pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
12.7B CNY 0.7 12.5 9.5 9.5
ZA
Clicks Group Ltd
JSE:CLS
72.6B Zac 0 0 0 0
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
28.3B Zac 0 0 0 0
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
14.9B USD 0.1 -2.5 5.2 11.5
BR
Raia Drogasil SA
BOVESPA:RADL3
45.1B BRL 1.3 42.8 13 23.1
CN
Yifeng Pharmacy Chain Co Ltd
SSE:603939
45.7B CNY 2 31.7 22.2 22.2
JP
MatsukiyoCocokara & Co
TSE:3088
945.8B JPY 0.9 18.7 9.3 11.9
SA
Al Nahdi Medical Company SCJSC
SAU:4164
17.8B SAR 2 19.9 11.2 18.4
MX
Corporativo Fragua SAB de CV
BMV:FRAGUAB
77.3B MXN 0.7 17.2 7.9 9.2
JP
Cosmos Pharmaceutical Corp
TSE:3349
596.8B JPY 0.7 24.8 11.7 18.8
CN
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
25.3B CNY 1 19.7 15 15

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.